Loading
companiesCompany
CSL Limited
CSL is the Australian plasma-products and vaccines group whose CSL Behring arm makes immunoglobulins and clotting factors used in supportive cancer care, and which has sponsored phase 3 trials in cancer settings.
Also called: CSL BehringCSL Behring LLCCSL Behring GmbHCommonwealth Serum LaboratoriesVifor Pharma
Overview
CSL Limited, listed in Melbourne since 1994 and descended from the Commonwealth Serum Laboratories, is one of the world's largest plasma-derived medicines makers through CSL Behring, based in King of Prussia, Pennsylvania, alongside its Seqirus vaccines business. In oncology its products are supportive: immunoglobulin replacement for patients with blood cancers or after CAR-T therapy, and haemostatic agents. ClinicalTrials.gov lists CSL Behring as lead sponsor of phase 3 trials in cancer-related settings.
Headquarters
Melbourne, AU
Scorecard
All companies#160of 1244 companies, score 37
- approved products +6
- modalities +2
- regions +1
- registry trials +28
1 approved, 0 in phase 3, 0 earlier, 0 targets, 195 registry studies. Formula on the scorecards page.
Type
Stage
Public
Website
Founded
1994
ApprovedPooled human polyclonal IgG antibody preparation (intravenous immunoglobulin)
Human normal immunoglobulin (IVIg) · Privigen / Kiovig
Intravenous immunoglobulin is pooled antibody from many blood donors. People with chronic lymphocytic leukaemia or myeloma whose own antibody levels have collapsed, and who keep getting bacterial infections despite antibiotics, receive it as replacement.
Similar pages
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
- CompanyCyclacel Pharmaceuticals
- CompanyVion Pharmaceuticals
fronts
drugs
ApprovedPooled human polyclonal IgG antibody preparation (intravenous immunoglobulin)
Human normal immunoglobulin (IVIg) · Privigen / Kiovig